Speaker illustration

Doctor Thomas Vanassche

University Hospitals (UZ) Leuven, Leuven (Belgium)

Member of:

European Society of Cardiology

Efficacy and safety of low-dose rivaroxaban on top of aspirin in patients with polypharmacy and multimorbidity: an analysis from the COMPASS trial

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Pharmacotherapy

Session: Optimizing Management of Chronic CAD – Squeeze on Big Data for Additional Info

Thumbnail

Risk factors and clinical outcomes in chronic CAD and PAD: an analysis of the randomized, double-blind COMPASS trial

Event: ESC CONGRESS 2019

Topic: Secondary Prevention

Session: Progress in secondary prevention - New treatments

Thumbnail

ESC 365 is supported by

logo Novo Nordisk